Vazyme Biotech

Since its establishment in 2012, Vazyme has dedicated itself to the mission of "Science and Technology Make a Healthier Life," focusing on technological innovation and continuously expanding the application fields of core technologies in life science, bio-medicine, and in vitro diagnostics. As an R&D-based company, Vazyme holds itself to the highest standards of ethics, accountability, and professionalism. The global research and development operations ensure the provision of quality products, solutions, and services locally to customers, present in more than 60 countries and regions worldwide.

Mission

Vazyme believes that a good purpose makes a good business, and good businesses contribute to a better world. Providing reliable products and services is the company's way of creating a brighter future for all. Customers specializing in key areas such as basic biological research, disease diagnosis development, biopharmaceuticals, and new treatments are supported by Vazyme to improve public health and save lives. As a young and energetic company, Vazyme gives 120% in everything it does, taking pride in the difference made to people's lives and to the world.

Responsibility

For University Cooperation and Public Health:

University Cooperation: Talents are a key driver of research and development. Committed to empowering healthy living with technical innovations, Vazyme teams up with universities to build a platform for academic exchanges, resource sharing, and talent development.

Public Health: "Science and Technology Make a Healthier Life" is not just a slogan for Vazyme; it is a commitment to society and the whole world. To help humans overcome epidemics, tumors, and autoimmune diseases, Vazyme played an important role in the fight against the African swine flu and COVID-19. The company was among the first to roll out COVID-19 testing solutions, providing detection kit manufacturers with key raw materials for about 500 million tests by June 2021. So far, the testing kits have reached more than 60 countries.

Global Network

As an innovator in technology, Vazyme sees continuous investment in the R&D of innovative solutions as a top priority. This ensures the company's capabilities in developing new products with innovative technologies and the ability to build a comprehensive product portfolio to address the various needs of global customers. In 2021, Vazyme expanded its global presence by setting up its first wholly-owned overseas subsidiary in Indonesia, with offices and warehouses in the US, the EU, and Hong Kong serving and supporting worldwide customers. In 2022, Vazyme is accelerating the expansion of its footprint in overseas markets with the foreseeable layout of more glocal business networks, including new branches, warehouses, R&D, and production bases.

Search for products by Vazyme Biotech